Harvey AG, Watkins E, Mansell W. Cognitive behavioural processes across psychological disorders: A transdiagnostic approach to research and treatment. USA: Oxford University Press; 2004.
Eaton WW, Martins SS, Nestadt G, Bienvenu OJ, Clarke D, Alexandre P. The burden of mental disorders. Epidemiol Rev. 2008;30:1–14.
Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655–79.
Sullivan PF, Daly MJ, O’Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet. 2012;13:537–51.
Opel N, Goltermann J, Hermesdorf M, Berger K, Baune BT, Dannlowski U. Cross-disorder analysis of brain structural abnormalities in six major psychiatric disorders: a secondary analysis of mega- and meta-analytical findings from the ENIGMA consortium. Biol Psychiatry. 2020;88:678–86.
Goodkind M, Eickhoff SB, Oathes DJ, Jiang Y, Chang A, Jones-Hagata LB, et al. Identification of a common neurobiological substrate for mental Illness. JAMA Psychiatry. 2015;72:305–15.
Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, Duncan L, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018;360:eaap8757.
Lee PH, Anttila V, Won H, Feng YCA, Rosenthal J, Zhu Z, et al. Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell. 2019;179:1469–82.
Lee PH, Feng YCA, Smoller JW. Pleiotropy and cross-disorder genetics among psychiatric disorders. Biol Psychiatry. 2021;89:20–31.
Schork AJ, Won H, Appadurai V, Nudel R, Gandal M, Delaneau O, et al. A genome-wide association study of shared risk across psychiatric disorders implicates gene regulation during fetal neurodevelopment. Nat Neurosci. 2019;22:353–61.
Bhattacharjee S, Rajaraman P, Jacobs KB, Wheeler WA, Melin BS, Hartge P, et al. A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits. Am J Hum Genet. 2012;90:821–35.
O’Leary A, Fernàndez-Castillo N, Gan G, Yang Y, Yotova AY, Kranz TM, et al. Behavioural and functional evidence revealing the role of RBFOX1 variation in multiple psychiatric disorders and traits. Mol Psychiatry. 2022;27:4464–73.
Vosberg DE, Leyton M, Flores C. The Netrin-1/DCC guidance system: dopamine pathway maturation and psychiatric disorders emerging in adolescence. Mol Psychiatry. 2019;25:297–307.
Bendriem RM, Ross ME. Wiring the human brain: a User’s handbook. Neuron. 2017;95:482–5.
Brie Wamsley A, Hubert Jaglin X, Favuzzi E, Khodadadi-Jamayran A, Rudy B, Fishell Correspondence G. Rbfox1 mediates cell-type-specific splicing in cortical interneurons. Neuron. 2018;100:846–59.
Fernàndez-Castillo N, Gan G, van Donkelaar MMJ, Vaht M, Weber H, Retz W, et al. RBFOX1, encoding a splicing regulator, is a candidate gene for aggressive behavior. Eur Neuropsychopharmacol. 2020;30:44–55.
Hamm AO. Fear, anxiety, and their disorders from the perspective of psychophysiology. Psychophysiology. 2020;57:e13474.
Siever LJ. Neurobiology of aggression and violence. Am J Psychiatry. 2008;165:429–42.
Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502–8.
Clarin JD, Reddy N, Alexandropoulos C, Gao WJ. The role of cell adhesion molecule IgSF9b at the inhibitory synapse and psychiatric disease. Neurosci Biobehav Rev. 2024;156:105476.
Woo J, Kwon SK, Nam J, Choi S, Takahashi H, Krueger D, et al. The adhesion protein IgSF9b is coupled to neuroligin 2 via S-SCAM to promote inhibitory synapse development. J Cell Biol. 2013;201:929.
Howes OD, Onwordi EC. The synaptic hypothesis of schizophrenia version III: a master mechanism. Mol Psychiatry. 2023;28:1843–56.
Le BD, Stein JL. Mapping causal pathways from genetics to neuropsychiatric disorders using genome-wide imaging genetics: current status and future directions. Psychiatry Clin Neurosci. 2019;73:357–69.
Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci. 2006;7:818–27.
Campbell M, Jahanshad N, Mufford M, Choi KW, Lee P, Ramesar R, et al. Overlap in genetic risk for cross-disorder vulnerability to mental disorders and genetic risk for altered subcortical brain volumes. J Affect Disord. 2021;282:740–56.
Cheng W, van der Meer D, Parker N, Hindley G, O’Connell KS, Wang Y, et al. Shared genetic architecture between schizophrenia and subcortical brain volumes implicates early neurodevelopmental processes and brain development in childhood. Mol Psychiatry. 2022;27:5167–76.
Cheng W, Frei O, Van Der Meer D, Wang Y, O’Connell KS, Chu Y, et al. Genetic association between schizophrenia and cortical brain surface area and thickness. JAMA Psychiatry. 2021;78:1020–30.
Jung K, Yoon J, Ahn Y, Kim S, Shim I, Ko H, et al. Leveraging genetic overlap between irritability and psychiatric disorders to identify genetic variants of major psychiatric disorders. Exp Mol Med. 2023;55:1193–202.
Gao J, Davis LK, Hart AB, Sanchez-Roige S, Han L, Cacioppo JT, et al. Genome-wide association study of loneliness demonstrates a role for common variation. Neuropsychopharmacology. 2016;42:811–21.
Hindley G, O’Connell KS, Rahman Z, Frei O, Bahrami S, Shadrin A, et al. The shared genetic basis of mood instability and psychiatric disorders: a cross-trait genome-wide association analysis. Am J Med Genet B Neuropsychiatr Genet. 2022;189:207–18.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA, US: American Psychiatric Publishing, Inc; 2013.
Wray NR, Lin T, Austin J, McGrath JJ, Hickie IB, Murray GK, et al. From basic science to clinical application of polygenic risk scores. JAMA Psychiatry. 2021;78:101–9.
Igo RP, Kinzy TG, Cooke Bailey JN. Genetic risk scores. Curr Protoc Hum Genet. 2019;104:e95.
Keaton JM, Kamali Z, Xie T, Vaez A, Williams A, Goleva SB, et al. Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits. Nat Genet. 2024;56:778–91.
Chagnon M, O’Loughlin J, Engert JC, Karp I, Sylvestre MP. Missing single nucleotide polymorphisms in genetic risk scores: a simulation study. PLoS ONE. 2018;13:e0200630.
Liu S, Smit DJA, Abdellaoui A, van Wingen GA, Verweij KJH. Brain structure and function show distinct relations with genetic predispositions to mental health and cognition. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023;8:300–10.
Stauffer EM, Bethlehem RAI, Warrier V, Murray GK, Romero-Garcia R, Seidlitz J, et al. Grey and white matter microstructure is associated with polygenic risk for schizophrenia. Mol Psychiatry. 2021;26:7709–18.
Schmitt S, Meller T, Stein F, Brosch K, Ringwald K, Pfarr JK, et al. Effects of polygenic risk for major mental disorders and cross-disorder on cortical complexity. Psychol Med. 2022;52:4127.
Leppert B, Millard LAC, Riglin L, Smith GD, Thapar A, Tilling K, et al. A cross-disorder PRS-pheWAS of 5 major psychiatric disorders in UK biobank. PLoS Genet. 2020;16:e1008185.
Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203–9.
Grasby KL, Jahanshad N, Painter JN, Colodro-Conde L, Bralten J, Hibar DP, et al. The genetic architecture of the human cerebral cortex. Science. 2020;367:eaay6690.
Hibar DP, Adams HHH, Jahanshad N, Chauhan G, Stein JL, Hofer E, et al. Novel genetic loci associated with hippocampal volume. Nat Commun. 2017;8:13624.
Satizabal CL, Adams HHH, Hibar DP, White CC, Knol MJ, Stein JL, et al. Genetic architecture of subcortical brain structures in 38,851 individuals. Nat Genet. 2019;51:1624–36.
McCutcheon RA, Pillinger T, Guo X, Rogdaki M, Welby G, Vano L, et al. Shared and separate patterns in brain morphometry across transdiagnostic dimensions. Nat. Mental Health. 2023;1:55–65.
Van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, et al. Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium. Biol Psychiatry. 2018;84:644–54.
Lahey BB. Public health significance of neuroticism. Am Psychol. 2009;64:241–56.
Chang CC, Chow CC, Tellier LCAM, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.
Choi SW, O’Reilly PF. PRSice-2: polygenic risk score software for biobank-scale data. Gigascience. 2019;8:giz082.
Han B, Eskin E. Interpreting meta-analyses of genome-wide association studies. PLoS Genet. 2012;8:e1002555.
Machiela MJ, Chanock SJ. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31:3555–7.
Miller KL, Alfaro-Almagro F, Bangerter NK, Thomas DL, Yacoub E, Xu J, et al. Multimodal population brain imaging in the UK biobank prospective epidemiological study. Nat Neurosci. 2016;19:1523–36.
Alfaro-Almagro F, Jenkinson M, Bangerter NK, Andersson JLR, Griffanti L, Douaud G, et al. Image processing and quality control for the first 10,000 brain imaging datasets from UK biobank. Neuroimage. 2018;166:400–24.
Esteban O, Markiewicz CJ, Blair RW, Moodie CA, Isik AI, Erramuzpe A, et al. fMRIPrep: a robust preprocessing pipeline for functional MRI. Nat Methods. 2018;16:111–6.
Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968–80.
Seabold S, Perktold J. Statsmodels: econometric and statistical modeling with python. SciPy. 2010;7:92–96.
Hoogman M, Muetzel R, Guimaraes JP, Shumskaya E, Mennes M, Zwiers MP, et al. Brain imaging of the cortex in ADHD: a coordinated analysis of large-scale clinical and population-based samples. Am J Psychiatry. 2019;176:531–42.
Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA bipolar disorder working group. Mol Psychiatry. 2018;23:932–42.
Hibar DP, Westlye LT, Van Erp TGM, Rasmussen J, Leonardo CD, Faskowitz J, et al. Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry. 2016;21:1710–6.
Boedhoe PSW, Schmaal L, Abe Y, Alonso P, Ameis SH, Anticevic A, et al. Cortical abnormalities associated with pediatric and adult obsessive-compulsive disorder: findings from the enigma obsessive-compulsive disorder working group. Am J Psychiatry. 2018;175:453–62.
Boedhoe PSW, Schmaal L, Abe Y, Ameis SH, Arnold PD, Batistuzzo MC, et al. Distinct subcortical volume alterations in pediatric and adult OCD: a worldwide meta- and mega-analysis. Am J Psychiatry. 2017;174:60–70.
Hoogman M, Bralten J, Hibar DP, Mennes M, Zwiers MP, Schweren LSJ, et al. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. Lancet Psychiatry. 2017;4:310–9.
Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis: I. Segmentation and surface reconstruction. Neuroimage. 1999;9:179–94.
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289–300.
Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50:668–81.
Hansen JY, Shafiei G, Vogel JW, Smart K, Bearden CE, Hoogman M, et al. Local molecular and global connectomic contributions to cross-disorder cortical abnormalities. Nat Commun. 2022;13:4682.
Parikshak NN, Gandal MJ, Geschwind DH. Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat Rev Genet. 2015;16:441–58.
Hwang K, Bertolero MA, Liu WB, D’Esposito M. The human thalamus is an integrative hub for functional brain networks. J Neurosci. 2017;37:5594–607.
Cheon EJ, Bearden CE, Sun D, Ching CRK, Andreassen OA, Schmaal L, et al. Cross disorder comparisons of brain structure in schizophrenia, bipolar disorder, major depressive disorder, and 22q11.2 deletion syndrome: a review of ENIGMA findings. Psychiatry Clin Neurosci. 2022;76:140–61.
Weeland CJ, Kasprzak S, de Joode NT, Abe Y, Alonso P, Ameis SH, et al. The thalamus and its subnuclei—a gateway to obsessive-compulsive disorder. Transl Psychiatry. 2022;12:1–10.
Hettwer MD, Larivière S, Park BY, van den Heuvel OA, Schmaal L, Andreassen OA, et al. Coordinated cortical thickness alterations across six neurodevelopmental and psychiatric disorders. Nat Commun. 2022;13:6851.
Etkin A, Egner T, Kalisch R. Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci. 2011;15:85–93.
Madre M, Canales-Rodríguez EJ, Fuentes-Claramonte P, Alonso-Lana S, Salgado-Pineda P, Guerrero-Pedraza A, et al. Structural abnormality in schizophrenia versus bipolar disorder: a whole brain cortical thickness, surface area, volume and gyrification analyses. Neuroimage Clin. 2020;25:102131.
Nenadic I, Yotter RA, Sauer H, Gaser C. Patterns of cortical thinning in different subgroups of schizophrenia. Br J Psychiatry. 2015;206:479–83.
Howes OD, Cummings C, Chapman GE, Shatalina E. Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes. Neuropsychopharmacology. 2022;48:151–67.
Gao X, Zhang W, Yao L, Xiao Y, Liu L, Liu J, et al. Association between structural and functional brain alterations in drug-free patients with schizophrenia: a multimodal meta-analysis. J Psychiatry Neurosci. 2018;43:131–42.
Elvevag B, Goldberg TE. Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol. 2000;14:1–21.
Schaefer J, Giangrande E, Weinberger DR, Dickinson D. The global cognitive impairment in schizophrenia: consistent over decades and around the world. Schizophr Res. 2013;150:42–50.
Nakamura M, Nestor PG, Levitt JJ, Cohen AS, Kawashima T, Shenton ME, et al. Orbitofrontal volume deficit in schizophrenia and thought disorder. Brain. 2008;131:180–95.
Kirschner M, Schmidt A, Hodzic-Santor B, Burrer A, Manoliu A, Zeighami Y, et al. Orbitofrontal-striatal structural alterations linked to negative symptoms at different stages of the schizophrenia spectrum. Schizophr Bull. 2021;47:849–63.
Kringelbach ML. The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci. 2005;6:691–702.
Alnæs D, Kaufmann T, Van Der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, et al. Brain heterogeneity in schizophrenia and its association with polygenic risk. JAMA Psychiatry. 2019;76:739–48.
Rodrigue AL, Mathias SR, Knowles EEM, Mollon J, Almasy L, Schultz L, et al. Specificity of psychiatric polygenic risk scores and their effects on associated risk phenotypes. Biol Psychiatry Glob Open Sci. 2023;3:519–29.
Cox J, Witten IB. Striatal circuits for reward learning and decision-making. Nat Rev Neurosci. 2019;20:482–94.
Luo X, Mao Q, Shi J, Wang X, Li CSR. Putamen gray matter volumes in neuropsychiatric and neurodegenerative disorders. World J Psychiatry Ment Health Res. 2019;3:1020.
Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry. 2011;68:128–37.
Van Erp TGM, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016;21:547–53.
Eysenck SBG, Eysenck HJ, Barrett P. A revised version of the psychoticism scale. Pers Individ Dif. 1985;6:21–9.
Costas J. The highly pleiotropic gene SLC39A8 as an opportunity to gain insight into the molecular pathogenesis of schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2018;177:274–83.
Carrera N, Arrojo M, Sanjuán J, Ramos-Ríos R, Paz E, Suárez-Rama JJ, et al. Association study of nonsynonymous single nucleotide polymorphisms in schizophrenia. Biol Psychiatry. 2012;71:169–77.
Hermann ER, Chambers E, Davis DN, Montgomery MR, Lin D, Chowanadisai W. Brain magnetic resonance imaging phenome-wide association study with metal transporter gene SLC39A8. Front Genet. 2021;12:647946.
Liu S, Abdellaoui A, H Verweij KJ, van Wingen GA, Verweij KJ. Replicable brain–phenotype associations require large-scale neuroimaging data. Nat Hum Behav. 2023;7:1344–56.
Smith DJ, Nicholl BI, Cullen B, Martin D, Ul-Haq Z, Evans J, et al. Prevalence and characteristics of probable major depression and bipolar disorder within UK biobank: cross-sectional study of 172,751 participants. PLoS ONE. 2013;8:e75362.
Podsakoff PM, MacKenzie SB, Lee JY, Podsakoff NP. Common method biases in behavioral research: a critical review of the literature and recommended remedies. J Appl Psychol. 2003;88:879–903.
Davis KA, Cullen B, Adams M, Brailean A, Breen G, Coleman JR, et al. Indicators of mental disorders in UK biobank—a comparison of approaches. Int J Methods Psychiatr Res. 2019;28:e1796.
Krosnick JA, Presser S Question and questionnaire design. In: Wright JD, Marsden PV, editors. Handbook of survey research. 2nd ed. Bingley, UK: Emerald Group Publishing; 2010. p. 263–313.
Hassanin E, May P, Aldisi R, Spier I, Forstner AJ, Nöthen MM, et al. Breast and prostate cancer risk: the interplay of polygenic risk, rare pathogenic germline variants, and family history. Genet Med. 2022;24:576–85.
Lecarpentier J, Silvestri V, Kuchenbaecker KB, Barrowdale D, Dennis J, McGuffog L, et al. Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores. J Clin Oncol. 2017;35:2240–50.
Buckholtz JW, Meyer-Lindenberg A. Psychopathology and the human connectome: toward a transdiagnostic model of risk for mental illness. Neuron. 2012;74:990–1004.
Amunts K, Mohlberg H, Bludau S, Zilles K. Julich-brain: a 3D probabilistic atlas of the human brain’s cytoarchitecture. Science. 2020;369:988–92.
Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munafò MR, et al. Mendelian randomization. Nat Rev Methods Primers. 2022;2:1–21.
Hindley G, Frei O, Shadrin AA, Cheng W, O’Connell KS, Icick R, et al. Charting the landscape of genetic overlap between mental disorders and related traits beyond genetic correlation. Am J Psychiatry. 2022;179:833–43.
Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet. 2013;14:483–95.